PATENT CLAIM ANALYSIS

Application Number: 15771845
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-10
Patent Classification: ["514", "263340"]

Abstract:
The invention discloses a crystal form A of a compound (I) and a preparation method thereof, and further discloses an application of the crystal form A as a PDE2 or TNF-α inhibitor.

Claim (Index 2):
A crystal form A of a compound (I) according to  claim 1 , wherein the peaks of the XRPD pattern of the crystal form A is shown as follow: NO. 2-Theta I % 1 9.578 100 2 10.43 40.1 3 12.502 18.2 4 13.996 4 5 15.086 7.7 6 15.38 16.5 7 16.287 7.4 8 16.661 6.3 9 17.428 85.8 10 17.646 29.8 11 18.298 11.3 12 19.977 10.2 13 20.427 10.2 14 20.879 29.7 15 21.314 8.6 16 22.141 31.1 17 22.928 6.4 18 23.387 4.4 19 24.27 4.6 20 24.548 39.8 21 25.116 3 22 25.834 9.5 23 26.719 5.3 24 27.665 3.6 25 29.477 16 26 30.956 5.6 27 32.416 3.4 28 34.623 3.4 29 37.243 3.5 30 39.237 3.6

Metadata:
- Claim Count in Document: 21.0
- Percentile: 91.0
- Lexical Diversity: 1.33333
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15517951', '15575037', '15575315', '15512412', '12066813']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7215455655547263
- 35 USC 102 Novelty (BERT): 0.5220789602945421
- Combined Prediction Score: 0.7015989050287078
- Mean Citation Score: 200.209468
- Max Citation Score: 257.63858
- Similarity Product: 157.47928961324212

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test